E B Garon

Pembrolizumab as first-line therapy for patients with PD-L1-positive advanced non-small cell lung cancer: a phase 1 trial

M. Ahn, E. Felip, K. Emancipator, 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

Identification of driver mutations in tumor specimens from 1,000 patients with lung adenocarcinoma: The NCI's Lung Cancer Mutation Consortium (LCMC).

G. Giaccone, A. Iafrate, C. Rudin, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.